Literature DB >> 21067974

Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function.

Thomas Condamine1, Dmitry I Gabrilovich.   

Abstract

Myeloid-derived suppressor cells (MDSCs) are one of the main cell populations responsible for regulating immune responses. MDSCs accumulate during tumor progression, autoimmunity, chronic infection and other pathological conditions, and can potently suppress T cell function. Recent studies have demonstrated the ability of MDSCs to modulate the activity of NK and myeloid cells and have implicated MDSCs in the induction of regulatory T cells. Here, we discuss recent findings that describe the molecular mechanisms that regulate the expansion and function of MDSCs, as well as recent attempts to use MDSCs in cell therapy for different pathologic conditions. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21067974      PMCID: PMC3053028          DOI: 10.1016/j.it.2010.10.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  75 in total

Review 1.  S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules.

Authors:  Dirk Foell; Helmut Wittkowski; Thomas Vogl; Johannes Roth
Journal:  J Leukoc Biol       Date:  2006-08-30       Impact factor: 4.962

2.  C/EBPbeta is required for 'emergency' granulopoiesis.

Authors:  Hideyo Hirai; Pu Zhang; Tajhal Dayaram; Christopher J Hetherington; Shin-ichi Mizuno; Jiro Imanishi; Koichi Akashi; Daniel G Tenen
Journal:  Nat Immunol       Date:  2006-06-04       Impact factor: 25.606

3.  STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion.

Authors:  Sergei Kusmartsev; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

4.  Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells.

Authors:  Giovanna Gallina; Luigi Dolcetti; Paolo Serafini; Carmela De Santo; Ilaria Marigo; Mario P Colombo; Giuseppe Basso; Frank Brombacher; Ivan Borrello; Paola Zanovello; Silvio Bicciato; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

5.  L-arginine availability regulates T-lymphocyte cell-cycle progression.

Authors:  Paulo C Rodriguez; David G Quiceno; Augusto C Ochoa
Journal:  Blood       Date:  2006-10-05       Impact factor: 22.113

Review 6.  Regulation of immune responses by L-arginine metabolism.

Authors:  Vincenzo Bronte; Paola Zanovello
Journal:  Nat Rev Immunol       Date:  2005-08       Impact factor: 53.106

7.  Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.

Authors:  Bo Huang; Ping-Ying Pan; Qingsheng Li; Alice I Sato; David E Levy; Jonathan Bromberg; Celia M Divino; Shu-Hsia Chen
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

8.  Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.

Authors:  Pratima Sinha; Virginia K Clements; Suzanne Ostrand-Rosenberg
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

9.  Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease.

Authors:  Pratima Sinha; Virginia K Clements; Suzanne Ostrand-Rosenberg
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

Review 10.  Altered macrophage differentiation and immune dysfunction in tumor development.

Authors:  Antonio Sica; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

View more
  376 in total

1.  Endoplasmic reticulum stress induced LOX-1 CD15+ polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma.

Authors:  Jiang Nan; Yan-Fang Xing; Bo Hu; Jian-Xin Tang; Hui-Min Dong; Yu-Mei He; Dan-Yun Ruan; Qing-Jian Ye; Jia-Rong Cai; Xiao-Kun Ma; Jie Chen; Xiu-Rong Cai; Ze-Xiao Lin; Xiang-Yuan Wu; Xing Li
Journal:  Immunology       Date:  2017-12-21       Impact factor: 7.397

2.  αB-Crystallin regulates expansion of CD11b⁺Gr-1⁺ immature myeloid cells during tumor progression.

Authors:  Lothar C Dieterich; Petter Schiller; Hua Huang; Eric F Wawrousek; Angelica Loskog; Alkwin Wanders; Lieve Moons; Anna Dimberg
Journal:  FASEB J       Date:  2012-10-02       Impact factor: 5.191

3.  Critical role of the mTOR pathway in development and function of myeloid-derived suppressor cells in lal-/- mice.

Authors:  Xinchun Ding; Hong Du; Mervin C Yoder; Cong Yan
Journal:  Am J Pathol       Date:  2013-11-26       Impact factor: 4.307

4.  In vivo ablation of plasmacytoid dendritic cells inhibits autoimmunity through expansion of myeloid-derived suppressor cells.

Authors:  Marianna Ioannou; Themis Alissafi; Louis Boon; Dimitrios Boumpas; Panayotis Verginis
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

5.  Defective TGF-β signaling in bone marrow-derived cells prevents hedgehog-induced skin tumors.

Authors:  Qipeng Fan; Dongsheng Gu; Hailan Liu; Ling Yang; Xiaoli Zhang; Mervin C Yoder; Mark H Kaplan; Jingwu Xie
Journal:  Cancer Res       Date:  2013-11-26       Impact factor: 12.701

6.  Adoptive transfer of IFN-γ-induced M-MDSCs promotes immune tolerance to allografts through iNOS pathway.

Authors:  Fan Yang; Yang Li; Weilong Zou; Yanan Xu; Hao Wang; Wei Wang; Yong Zhao
Journal:  Inflamm Res       Date:  2019-05-04       Impact factor: 4.575

7.  Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity.

Authors:  William L Redmond; Stefanie N Linch; Melissa J Kasiewicz
Journal:  Cancer Immunol Res       Date:  2013-11-11       Impact factor: 11.151

8.  Myeloid-derived suppressor cells in the development of lung cancer.

Authors:  Myrna L Ortiz; Lily Lu; Indu Ramachandran; Dmitry I Gabrilovich
Journal:  Cancer Immunol Res       Date:  2013-10-18       Impact factor: 11.151

9.  Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans.

Authors:  Güllü Topal Görgün; Gregory Whitehill; Jennifer L Anderson; Teru Hideshima; Craig Maguire; Jacob Laubach; Noopur Raje; Nikhil C Munshi; Paul G Richardson; Kenneth C Anderson
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

10.  Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5.

Authors:  Yong Wang; Cara C Schafer; Kenneth P Hough; Sultan Tousif; Steven R Duncan; John F Kearney; Selvarangan Ponnazhagan; Hui-Chen Hsu; Jessy S Deshane
Journal:  J Immunol       Date:  2018-05-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.